Company Filing History:
Years Active: 2010-2018
Title: Innovative Contributions of Orla Hardiman in Neurodegenerative Disease Treatment
Introduction
Orla Hardiman, an esteemed inventor located in Dublin, Ireland, has made significant strides in the field of neurodegenerative diseases. With four patents to her name, her research and inventions focus on utilizing angiogenin to treat conditions characterized by neuronal injury and axonal degeneration.
Latest Patents
Hardiman's most recent patents delve into the treatment of diseases such as Amyotrophic Lateral Sclerosis (ALS). The inventions revolve around the application of angiogenin, alongside its fragments and variants, to manage conditions wherein neuronal death or injury is prevalent. Additionally, her patents outline various mutations of the human angiogenin gene that are associated with neurodegenerative diseases, particularly highlighting those linked to the ALS phenotype. Moreover, these inventions include methods to assess whether an individual is afflicted by, or genetically predisposed to, diseases characterized by neuronal injury or axonal degeneration.
Career Highlights
Orla Hardiman is affiliated with the Royal College of Surgeons in Ireland, where she engages in pioneering research that integrates medical science and innovation. Her commitment to advancing medical knowledge and treatments for neurodegenerative diseases has positioned her as a leading figure in her field.
Collaborations
In her professional journey, Hardiman collaborates with other experts, including her coworker Matt Greenway. Together, they work on exploring new frontiers in the understanding of neurodegenerative diseases and seek innovative ways to address these complex health challenges.
Conclusion
Orla Hardiman's contributions to the realm of neurodegenerative disease treatment through her patented innovations emphasize her role as a pivotal figure in medical research. Her work not only sheds light on the mechanisms of diseases like ALS but also paves the way for potential therapeutic advancements, reinforcing the importance of collaboration and innovation in addressing pressing health issues.